Specific Safety Profile of Bevacizumab in Asian Patients With Advanced NSCLC: A Meta-Analysis

Randomized studies have obtained varying findings regarding the benefits and toxicities of bevacizumab in the treatment of nonsmall cell lung cancer (NSCLC). It is unclear whether the discrepancies among trials are due to ethnic/racial differences. We therefore performed a meta-analysis of all publi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhenguang, Zhong, Beilong, Lun, Xueping, Lai, Yingrong, Bella, Amos Ela, Yang, Weilin, Wu, Jiabin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616559/
https://www.ncbi.nlm.nih.gov/pubmed/26091469
http://dx.doi.org/10.1097/MD.0000000000000975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616559/
https://www.ncbi.nlm.nih.gov/pubmed/26091469
http://dx.doi.org/10.1097/MD.0000000000000975

Ejemplares similares